Lipocine
LPCN
#10774
Rank
NZ$33.79 M
Marketcap
NZ$3.05
Share price
9.55%
Change (1 day)
-40.58%
Change (1 year)

Operating Margin for Lipocine (LPCN)

Operating Margin as of November 2026 (TTM): -800.82%

According to Lipocine's latest financial reports and stock price the company's current Operating Margin is -800.82%. At the end of 2021 the company had an Operating Margin of -3.93%.

Operating Margin history for Lipocine from 2021 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2021-3.93%
2019-7,883.60%189.42%
2018-2,723.94%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Seagen
SGEN
-30.69%-96.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
15.81%-101.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Agile Therapeutics
AGRX
-69.66%-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.